Pharmaceutical Companies-Pharmaceutical Industry-Government Programs-340B Program

More Pharma at Government Programs Than Any Other Event

While the recently released Proposed Rule has the pharmaceutical industry scrambling to begin to strategize how it might need to adapt and change post- Final Rule, the AMP guidance is not the only thing the pharmaceutical industry is talking about.
At the Government Programs Summit, industry professionals will be on hand to discuss not only the AMP Rule, but the 340B pricing program, Medicare Part D, Medicaid Managed Care, Medicare Part B, ASP Pricing and State reimbursement. You will walk away with a thorough knowledge of how various pharmaceutical companies are addressing current challenges and questions with each program to take back and implement at your office.
Session Highlights:
? Improve the Integrity of the 340B Program
? Impact on Manufacturer of Multiple Mechanisms for Reimbursement from States
? Strategies to Overcome the Implementation and Process Challenges of Part D
For more information and these sessions, download the brochure here.
The Government Programs Summit this March 14-16, 2012 in Baltimore, MD!  If you have any questions about the program, please feel free to contact Jennifer Pereira at jpereira@iirusa.com. read more..